Experimental brain cancer treatment combines DNA vaccine with immune therapy
Disease control
Ongoing
This trial is testing whether combining a DNA vaccine (INO-5401 and INO-9012) with an immune checkpoint inhibitor drug (cemiplimab) can help fight newly-diagnosed glioblastoma, an aggressive brain cancer. The treatment is given alongside standard radiation and chemotherapy to 52 …
Phase: PHASE1, PHASE2 • Sponsor: Inovio Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC